Back to funds
View filing
Melqart Asset Management (UK) Ltd
hedge fundUpdated 27 days agoManaged by Melqart Asset Management (Uk) Ltd • Latest filing Q2 2026
Portfolio value
$1.1B
Q2 2026
Filings
13
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 13 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q2 2023 | $1.3B |
| Q3 2023 | $1.4B |
| Q4 2023 | $1.4B |
| Q1 2024 | $1.6B |
| Q2 2024 | $1.2B |
| Q3 2024 | $1.1B |
| Q4 2024 | $828.2M |
| Q1 2025 | $767.1M |
| Q2 2025 | $699.7M |
| Q3 2025 | $749.5M |
| Q4 2025 | $1B |
| Q1 2026 | $1B |
| Q2 2026 | $1.1B |
Top holdings
40 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | W WMT WARNER BROS DISCOVERY INC | $122.2M | 4.58M | 11.63% | — |
| 2 | T TXNM TXNM ENERGY INC | $77.8M | 1.37M | 7.40% | — |
| 3 | N NSC NORFOLK SOUTHN CORP | $76.4M | 242.9K | 7.27% | — |
| 4 | E EA ELECTRONIC ARTS INC | $73M | 356.3K | 6.95% | — |
| 5 | C CYTK CYTOKINETICS INC | $65.4M | 767.5K | 6.22% | — |
| 6 | P PEN PENUMBRA INC | $58.6M | 185.7K | 5.58% | — |
| 7 | G GTLS CHART INDS INC | $44.8M | 214.6K | 4.27% | — |
| 8 | A AAVXF ABIVAX SA | $40.9M | 307.3K | 3.90% | — |
| 9 | G GPN GLOBAL PMTS INC | $38.7M | 532.7K | 3.68% | — |
| 10 | A AES AES CORP | $30.8M | 2.10M | 2.93% | — |
| 11 | A AMD ADVANCED MICRO DEVICES INC | $27.3M | 47.0K | 2.60% | — |
| 12 | A ASMLF ASML HLDG NV | $25.5M | 12.8K | 2.43% | — |
| 13 | N NVDA NVIDIA CORPORATION | $24.9M | 124.4K | 2.37% | — |
| 14 | I INDV INDIVIOR PHARMACEUTICALS INC | $24M | 585.7K | 2.29% | — |
| 15 | R RVMDW REVOLUTION MEDICINES INC | $22.7M | 121.3K | 2.16% | — |
| 16 | U UNF UNIFIRST CORP MASS | $22.4M | 84.9K | 2.14% | — |
| 17 | T TSMWF TAIWAN SEMICONDUCTOR MANUFAC | $20.5M | 42.9K | 1.95% | — |
| 18 | C CZR CAESARS ENTERTAINMENT INC NE | $20.1M | 665.4K | 1.91% | — |
| 19 | A AMZN AMAZON COM INC | $16.2M | 68.1K | 1.55% | — |
| 20 | A APGE APOGEE THERAPEUTICS INC | $15.6M | 117.2K | 1.48% | — |